Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer

ConclusionsLND is associated with a 48% reduction in risk of death in patients with resectable non-metastatic GBC, with greatest impact in pT2 –3 patients. Patients without LND have similar OS to patients with node-positive disease, highlighting the importance of LND. Underutilization of LND likely results in undertreatment of patients with undiagnosed nodal disease, which may contribute to unfavorable oncologic outcomes.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research